Avoro Capital Advisors’s Fortress Biotech FBIO Stock Holding History

Avoro Capital Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-40,244	Closed	-$2.87M	–	45
2017 Q2	$2.87M	Sell	40,244 -26,200	-39%	-$1.55M	0.36%	32
2017 Q1	$3.69M	Sell	66,444 -13,579	-17%	-$607K	0.47%	33
2016 Q4	$3.24M	Sell	80,023 -10,419	-12%	-$389K	0.65%	29
2016 Q3	$4.03M	Buy	90,442 +2,000	+2%	+$85.1K	0.71%	30
2016 Q2	$3.57M	Sell	88,442 -749	-0.8%	-$34.9K	0.79%	26
2016 Q1	$4.15M	Hold	89,191	–	–	1.45%	20
2015 Q4	$3.73M	Buy	89,191 +4,156	+5%	+$174K	1.29%	21
2015 Q3	$3.32M	Buy	85,035 +23,066	+37%	+$1.08M	0.86%	24
2015 Q2	$3.12M	Buy	61,969 +21,969	+55%	+$1.13M	0.86%	25
2015 Q1	$2.31M	Buy	+40,000	New	+$1.67M	0.89%	25

Other funds holding FBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Avoro Capital Advisors's FBIO Position: Q3 2017 in Review

Avoro Capital Advisors sold out of Fortress Biotech (FBIO) in Q3 2017, closing a stake of 40,244 shares — an estimated $2.87M sold.

Avoro Capital Advisors first reported a position in FBIO in Q1 2015 and held it in 10 quarters. The position peaked at $4.15M in Q1 2016. 58 funds tracked by Wall St. Rank hold FBIO as of Q3 2017.

Avoro Capital Advisors reported no remaining Fortress Biotech position as of Q3 2017 after selling out during the quarter.
Avoro Capital Advisors sold 40,244 Fortress Biotech shares in Q3 2017, an estimated $2.87M.
Avoro Capital Advisors first reported a position in Fortress Biotech in Q1 2015 and held it in 10 quarters.
Avoro Capital Advisors's Fortress Biotech position peaked at $4.15M in Q1 2016.
58 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2017.

Based on Avoro Capital Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.